Sandborn WJ. et al.
An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn’s disease. Am J Gastroenterol 2004; 99: 1984-1989
Download Bibliographical Data
We do not assume any responsibility for the contents of the web pages of other providers.